Vpu Inhibitor Candidate

BIT225 is a new type of antiviral called a Vpu inhibitor, which researchers are investigating to treat both HIV and HIV/hepatitis C (HCV) co-infection....

Cure Activism 101

Destination: Cure First Steps You’d like to get involved in cure activism—where do you start? by Jeannie Wraight If you’d like to help in the fight to find...

Expediting Research

GlaxoSmithKline (GSK) and the University of North Carolina at Chapel-Hill (UNC) will launch a jointly owned novel HIV Cure Center, as well as a...

Talking “Cure”

Nobel Prize Laureate and world renowned HIV researcher Françoise Barré-Sinoussi recently made the statement that she does not believe an HIV cure is possible....

Orphaned Vaccines

Sometimes viewing a complex issue in its most simplistic form can help us to understand where a problem lies. HIV is a virus that...

Eye on the Future

Towards an HIV Cure is an initiative of the International AIDS Society (IAS) formed to help direct and facilitate discussion, research and policy to...

Broad Spectrum Antivirals: Part I

Spectrum Analysis Broad spectrum antivirals shift the drug model paradigm by Jeannie Wraight The recent spread of emerging pandemic viruses such as Zika and Ebola has increased...

LATEST POSTS

Morning & Test Trials: Two Poems by Joy Gaines-Friedler

Morning 8/8/90: “Not to worry!!! I want to get better. I don’t want to suffer anguish, anxiety and mental pain anymore. I can’t live like...

Boy Radio: Advocate

Bruce Ward: March 2008

Edmund White Honored by PEN